HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shu-Fen Peng Selected Research

demethoxycurcumin

11/2021Demethoxycurcumin Promotes Macrophage Cell Population and Phagocytosis in WEHI-3 Cell-generated Leukemia BALB/c Mice In Vivo.
5/2021Demethoxycurcumin Suppresses Human Brain Glioblastoma Multiforme GBM 8401 Cell Xenograft Tumor in Nude Mice In Vivo.
4/2021Demethoxycurcumin Suppresses Proliferation, Migration, and Invasion of Human Brain Glioblastoma Multiforme GBM 8401 Cells via PI3K/Akt Pathway.
9/2020Demethoxycurcumin Inhibits In Vivo Growth of Xenograft Tumors of Human Cervical Cancer Cells.
5/2018Curcuminoids combined with gefitinib mediated apoptosis and autophagy of human oral cancer SAS cells in vitro and reduced tumor of SAS cell xenograft mice in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shu-Fen Peng Research Topics

Disease

48Neoplasms (Cancer)
03/2022 - 08/2010
11Neoplasm Metastasis (Metastasis)
10/2021 - 07/2013
9Leukemia
11/2021 - 09/2017
8Lung Neoplasms (Lung Cancer)
03/2022 - 03/2013
7Osteosarcoma (Osteogenic Sarcoma)
09/2021 - 08/2013
6Glioblastoma (Glioblastoma Multiforme)
01/2022 - 11/2018
6Mouth Neoplasms (Oral Cancer)
09/2020 - 10/2013
5Body Weight (Weight, Body)
09/2020 - 05/2018
3Stomach Neoplasms (Stomach Cancer)
10/2021 - 11/2016
3Breast Neoplasms (Breast Cancer)
09/2021 - 12/2012
3Nasopharyngeal Carcinoma
07/2020 - 10/2016
3Prostatic Neoplasms (Prostate Cancer)
12/2019 - 07/2018
2Melanoma (Melanoma, Malignant)
01/2021 - 08/2018
2Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2020 - 09/2020
2Liver Neoplasms (Liver Cancer)
01/2020 - 06/2013
2Carcinoma (Carcinomatosis)
07/2019 - 12/2016
2Urinary Bladder Neoplasms (Bladder Cancer)
04/2019 - 03/2013
2Skin Neoplasms (Skin Cancer)
08/2018 - 03/2017
2Hepatocellular Carcinoma (Hepatoma)
01/2017 - 10/2012
1Ataxia (Dyssynergia)
07/2021
1Ataxia Telangiectasia (Louis Bar Syndrome)
07/2021
1B-Cell Lymphoma (Lymphoma, B Cell)
09/2020
1Acute Promyelocytic Leukemia
01/2020
1Colonic Neoplasms (Colon Cancer)
12/2019

Drug/Important Bio-Agent (IBA)

13Proteins (Proteins, Gene)FDA Link
01/2022 - 11/2016
8Biological ProductsIBA
01/2022 - 10/2016
7Pharmaceutical PreparationsIBA
01/2022 - 12/2016
7CurcuminIBA
05/2021 - 10/2013
6casticinIBA
09/2020 - 02/2018
6Antineoplastic Agents (Antineoplastics)IBA
07/2020 - 10/2016
5CaspasesIBA
03/2022 - 11/2016
5demethoxycurcuminIBA
11/2021 - 05/2018
5Reactive Oxygen Species (Oxygen Radicals)IBA
03/2021 - 10/2013
5Gefitinib (Iressa)FDA Link
11/2019 - 12/2016
4bufalinIBA
03/2022 - 10/2012
4bisdemethoxycurcuminIBA
01/2022 - 12/2016
4tetrandrineIBA
11/2021 - 10/2016
3Caspase 3 (Caspase-3)IBA
01/2022 - 05/2018
3Ouabain (G Strophanthin)IBA
09/2021 - 12/2019
3Matrix Metalloproteinases (MMPs)IBA
09/2021 - 05/2018
3BerberineIBA
11/2018 - 02/2011
3PolymersIBA
09/2017 - 01/2009
3DNA (Deoxyribonucleic Acid)IBA
01/2017 - 08/2013
2phenethyl isothiocyanate (PEITC)IBA
01/2022 - 01/2018
2Dimethyl Sulfoxide (DMSO)FDA LinkGeneric
11/2021 - 05/2021
2Phosphates (Orthophosphate)IBA
11/2021 - 05/2021
2SolutionsIBA
11/2021 - 05/2021
2DiarylheptanoidsIBA
11/2021 - 05/2018
2allyl isothiocyanateIBA
09/2021 - 12/2012
22,3,4-tri-O-acetylarabinopyranosyl isothiocyanate (AITC)IBA
09/2021 - 12/2012
2BenzylisoquinolinesIBA
07/2021 - 10/2016
2AlkaloidsIBA
07/2021 - 10/2016
2Tryptophan (L-Tryptophan)FDA Link
01/2021 - 12/2019
2Peptides (Polypeptides)IBA
01/2021 - 12/2019
2Lysine (L-Lysine)FDA Link
01/2021 - 12/2019
2maslinic acidIBA
12/2020 - 01/2019
2TriterpenesIBA
12/2020 - 01/2019
2cardamoninIBA
04/2020 - 01/2019
2Cantharidin (Cantharides)IBA
10/2019 - 03/2017
2Ethanol (Ethyl Alcohol)IBA
07/2019 - 07/2018
2fisetinIBA
05/2019 - 01/2019
2FlavonoidsIBA
01/2019 - 08/2013
2chan su (ChanSu)IBA
01/2019 - 12/2016
2Heparin (Liquaemin)FDA LinkGeneric
11/2018 - 02/2011
2benzyl isothiocyanateIBA
11/2018 - 09/2018
2Cisplatin (Platino)FDA LinkGeneric
01/2014 - 10/2013
2matrigelIBA
08/2013 - 07/2013
2kaempferolIBA
08/2013 - 06/2013
1Sorafenib (BAY 43-9006)FDA Link
03/2022
1antiglomerular basement membrane antibodyIBA
01/2022
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
01/2022
1Phosphatidylinositols (Phosphatidylinositol)IBA
01/2022
1CytokinesIBA
01/2022
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2022
1Hematoxylin (Haematoxylon)IBA
11/2021
1Eosine Yellowish-(YS) (Eosin)IBA
11/2021
1Melitten (Melittin)IBA
10/2021
1Apoptosis Regulatory ProteinsIBA
07/2021
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
07/2021
1Caspase 8 (Caspase-8)IBA
07/2021
1Caspase 9IBA
07/2021
1Histones (Histone)IBA
07/2021
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
03/2021
1pterostilbeneIBA
03/2021
1peptide AIBA
01/2021
1NF-kappa B (NF-kB)IBA
01/2021
1PolyphenolsIBA
09/2020
1mangiferinIBA
09/2020
1Fluorouracil (Carac)FDA LinkGeneric
09/2020
1Cytochromes c (Cytochrome c)IBA
09/2020
1Indicators and Reagents (Reagents)IBA
04/2020
1Drug CombinationsIBA
01/2020
1RetinoidsIBA
01/2020
1Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2020
1AcidsIBA
01/2020
1Adenosine Monophosphate (AMP)IBA
12/2019
1Antimicrobial Cationic PeptidesIBA
12/2019

Therapy/Procedure

9Therapeutics
03/2022 - 07/2013
1Drug Therapy (Chemotherapy)
03/2022
1Aftercare (After-Treatment)
11/2021